Chemoinformaics analysis of PI-phosphatidylinositol
| Molecular Weight | 863.12 | nRot | 38 |
| Heavy Atom Molecular Weight | 779.456 | nRig | 12 |
| Exact Molecular Weight | 862.557 | nRing | 1 |
| Solubility: LogS | -2.19 | nHRing | 0 |
| Solubility: LogP | 8.818 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 142 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 59 | No. of Aromatic Carbocycles | 0 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 83 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 45 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 0 |
| nHA | 12 | APOL | 144.55 |
| nHD | 6 | BPOL | 100.654 |
| QED | 0.017 |
| Synth | 4.958 |
| Natural Product Likeliness | 0.733 |
| NR-PPAR-gamma | 0.926 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.057 |
| HIA | 0.778 |
| CACO-2 | -5.295 |
| MDCK | 0.00000707 |
| BBB | 0.008 |
| PPB | 0.995737 |
| VDSS | 0.698 |
| FU | 0.0186741 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.055 |
| CYP2c19-inh | 0.046 |
| CYP2c19-sub | 0.027 |
| CYP2c9-inh | 0.137 |
| CYP2c9-sub | 0.998 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.012 |
| CYP3a4-inh | 0.302 |
| CYP3a4-sub | 0.003 |
| CL | 0.871 |
| T12 | 0.083 |
| hERG | 0.231 |
| Ames | 0.014 |
| ROA | 0 |
| SkinSen | 0.96 |
| Carcinogencity | 0.412 |
| EI | 0.009 |
| Respiratory | 0.321 |
| NR-Aromatase | 0.18 |
| Antiviral | Yes |
| Prediction | 0.696574 |